<DOC>
	<DOC>NCT02655029</DOC>
	<brief_summary>The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.</brief_summary>
	<brief_title>Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination</brief_title>
	<detailed_description>This is a non-interventional study aiming to record adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination. In parallel blood pressure levels will be recorded, as well as safety and tolerability of this fixed dose combination.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Indapamide</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<criteria>Male or female, ambulatory patients &gt;18 years old. Clinically diagnosed essential arterial hypertension. Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination. The patient has given his/her written consent after being informed, before his inclusion in the study. Secondary arterial hypertension. Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event with serious residual lesions, scheduled procedure or surgical operation or hospital admission. Pregnancy, lactation or intention to become pregnant.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>